[Etiologies of cerebral palsy and classical treatment possibilities]
1Klinische Abteilung für Neonatologie, Universitätsklinik für Kinder- und Jugendheilkunde, Auenbruggerplatz 30, A-8036 Graz. ute.maurer@kfunigraz.ac.at
Insights
Cerebral palsy is a non-progressive brain disorder resulting from early-life damage, with cystic periventricular leukomalacia being a key cause. Prevalence varies, notably higher in very low birth weight infants, necessitating diverse therapeutic interventions.
Area of Science:
- Neurology
- Developmental Pediatrics
- Neuroscience
Context:
- Cerebral palsy (CP) is a non-progressive disorder impacting the developing brain.
- Etiologies span pre-, peri-, and postnatal periods, with cystic periventricular leukomalacia (PVL) being a primary concern.
- Damage to the first motor neuron is the consistent underlying cause of CP.
Purpose:
- To outline the etiologies and prevalence of cerebral palsy.
- To highlight the significant impact on very low birth weight (VLBW) infants.
- To review established therapeutic approaches for managing CP.
Summary:
- Key etiologies include cystic periventricular leukomalacia (PVL), intra-/periventricular hemorrhage, hypoxic-ischemic encephalopathy, vascular issues, infections, and brain malformations.
- Prevalence in Europe is 2-3 per 1000 live births, with 10-20% of very low birth weight (VLBW) infants in NICU settings affected.
- Therapeutic interventions encompass physiotherapy (e.g., Bobath, Vojta), speech and occupational therapy (e.g., Castillo-Morales, Sensory Integration), and other concepts (e.g., Petö, Affolter).
Impact:
- Understanding CP's diverse causes and high prevalence in vulnerable populations is crucial for early intervention.
- This review provides a foundation for exploring advanced diagnostic and therapeutic strategies.
- Highlights the need for specialized care and targeted therapies for affected infants, particularly VLBW infants.
Abstract:
Cerebral palsy is a non-progressive disorder of the developing brain with different etiologies in the pre-, peri- or postnatal period. The most important of these diseases is cystic periventricular leukomalacia (PVL), followed by intra- and periventricular hemorrhage, hypoxic-ischemic encephalopathy, vascular disorders, infections or brain malformations. The underlying cause is always a damage of the first motor neuron. Prevalence of cerebral palsy in Europe is 2-3 per 1000 live births with a broad spectrum in different birth weight groups. Our own data concerning only pre-term infants in the NICU with birth weight below 1500 g (VLBW) are between 10%-20%. Established classical treatment methods include physiotherapy (Bobath, Vojta, Hippotherapy), methods of speech and occupational therapists (Castillo-Morales, Sensory Integration) and other therapeutical concepts (Petö, Affolter, Frostig).
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Parkinson Disease l: Introduction
Alterations in Muscle Tone ll


